v3.26.1
Condensed Statements of Changes in Stockholders' Deficit - USD ($)
$ in Thousands
Total
Public Equity Offering - ATM
Common Stock
Common Stock
Public Equity Offering - ATM
Additional Paid-in Capital
Additional Paid-in Capital
Public Equity Offering - ATM
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024     91,413,742        
Beginning balance at Dec. 31, 2024 $ (60,156)   $ 91   $ 302,967   $ (363,214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common Stock issued under public equity offering-ATM (in shares)       7,457,627      
Common Stock issued under public equity offering-ATM   $ 22,000   $ 8   $ 21,992  
Costs of Common Stock issued under public equity offering-ATM   (729)       (729)  
Share-based compensation expense 1,587       1,587    
Vested restricted stock units, net (in shares)     445,784        
Vested restricted stock units, net (702)       (702)    
Net loss (22,930)           (22,930)
Ending balance (in shares) at Mar. 31, 2025     99,317,153        
Ending balance at Mar. 31, 2025 (60,930)   $ 99   325,115   (386,144)
Beginning balance (in shares) at Dec. 31, 2024     91,413,742        
Beginning balance at Dec. 31, 2024 (60,156)   $ 91   302,967   (363,214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (36,478)            
Ending balance (in shares) at Jun. 30, 2025     99,353,270        
Ending balance at Jun. 30, 2025 (72,590)   $ 99   327,003   (399,692)
Beginning balance (in shares) at Mar. 31, 2025     99,317,153        
Beginning balance at Mar. 31, 2025 (60,930)   $ 99   325,115   (386,144)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Costs of Common Stock issued under public equity offering-ATM   (34)       (34)  
Shares issued under employee stock purchase plan (in shares)     18,056        
Shares issued under employee stock purchase plan 59       59    
Share-based compensation expense 1,875       1,875    
Vested restricted stock units, net (in shares)     10,561        
Vested restricted stock units, net (19)       (19)    
Options exercises, net (in shares)     7,500        
Options exercised, net 7       7    
Net loss (13,548)           (13,548)
Ending balance (in shares) at Jun. 30, 2025     99,353,270        
Ending balance at Jun. 30, 2025 (72,590)   $ 99   327,003   (399,692)
Beginning balance (in shares) at Dec. 31, 2025     122,044,299        
Beginning balance at Dec. 31, 2025 (33,662)   $ 122   413,214   (446,998)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common Stock issued under public equity offering-ATM (in shares)       1,191,071      
Common Stock issued under public equity offering-ATM   5,062   $ 1   5,061  
Costs of Common Stock issued under public equity offering-ATM   (303)       (303)  
Warrants issued under the Purchase Agreement 916       916    
Share-based compensation expense 2,318       2,318    
Vested restricted stock units, net (in shares)     1,048,422        
Vested restricted stock units, net (329)   $ 1   (330)    
Options exercises, net (in shares)     750        
Options exercised, net 1       1    
Net loss (8,057)           (8,057)
Ending balance (in shares) at Mar. 31, 2026     124,284,542        
Ending balance at Mar. 31, 2026 (34,054)   $ 124   420,877   (455,055)
Beginning balance (in shares) at Dec. 31, 2025     122,044,299        
Beginning balance at Dec. 31, 2025 (33,662)   $ 122   413,214   (446,998)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (30,921)            
Ending balance (in shares) at Jun. 30, 2026     125,511,648        
Ending balance at Jun. 30, 2026 (56,586)   $ 126   421,207   (477,919)
Beginning balance (in shares) at Mar. 31, 2026     124,284,542        
Beginning balance at Mar. 31, 2026 (34,054)   $ 124   420,877   (455,055)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Costs of Common Stock issued under public equity offering-ATM   $ (79)       $ (79)  
Warrants issued under the Credit Agreement 663       663    
Shares issued under employee stock purchase plan (in shares)     19,660        
Shares issued under employee stock purchase plan 82       82    
Share-based compensation expense 2,880       2,880    
Vested restricted stock units, net (in shares)     1,172,446        
Vested restricted stock units, net (3,241)   $ 2   (3,243)    
Options exercises, net (in shares)     35,000        
Options exercised, net 27       27    
Net loss (22,864)           (22,864)
Ending balance (in shares) at Jun. 30, 2026     125,511,648        
Ending balance at Jun. 30, 2026 $ (56,586)   $ 126   $ 421,207   $ (477,919)